Mediconomics GmbH is a privately-held, full-service Contract Research Organization (CRO) founded in 2017, with its operational head office in Hanover, Germany. The company leverages over 25 years of collective team experience to offer tailored clinical research, regulatory strategy, and product development consulting services across multiple therapeutic areas. As a service provider, its business model is fee-for-service, generating revenue by supporting client programs from concept through post-marketing surveillance, without developing its own therapeutic assets.
Integrated clinical research and regulatory services platform, including clinical data management systems, eCTD submission capabilities, and pharmacovigilance databases. Expertise spans full drug/device development lifecycle.
Funding History
2
Total raised:$15M
Series A$12MBtov Partners
Seed$3MHigh-Tech Gründerfonds
Opportunities
Growing biotech sector and increased outsourcing of R&D functions create steady demand for flexible, full-service CROs.
The company's collaboration with its medical device manufacturing sister company, Medicoforum, provides a unique integrated offering for medtech clients.
Expansion of service lines into high-growth areas like real-world evidence and advanced therapies represents a potential growth vector.
Risk Factors
Intense competition from large, global CROs with greater resources poses a significant market challenge.
Operational risk is high, as service quality errors can damage reputation and lead to client loss.
The business is susceptible to downturns in biotech funding, which can reduce new clinical trial starts from its core SME client base.
Competitive Landscape
Mediconomics competes in the fragmented global CRO market, dominated by large players like IQVIA, ICON, and Parexel. Its differentiation is based on flexibility, personalized service, and full-service integration for small-to-midsize clients. It also competes with numerous regional and niche CROs across Europe, where reputation and therapeutic expertise are key competitive factors.
